Form 4 · PG
Procter & Gamble CEO- Health Care Paul Gama reports selling 2,225 shares
Paul Gama, Procter & Gamble's CEO- Health Care, filed a Form 4 on Oct 6, 2026 at 4:11 PM ET reporting transactions on Oct 5, 2026.
The filing reports 2,225 shares in an open-market or private sale (code S) at $145.34, about $323,382 in total.
The filing does not indicate that the sales were made under a Rule 10b5-1 trading plan.
After these transactions, the filing lists about 51,124 shares held directly.
Effect on holdings
Taken together, the rows reported here lowered Paul Gama's directly held shares by 4.2%, from about 53,349 to about 51,124.
Reporting person
- Paul Gama, CEO- Health Care (as filed: Gama Paul)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | S | Common Stock | 2,225 | $145.34 | Disposed | 51,124 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Oct 6, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Procter & Gamble company file → · More Procter & Gamble filings
Disclosures
- Editor holdings in PG
- The editor holds no position in Procter & Gamble (PG). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold PG.